The present invention is on the field of prevention and/or treatment of adipogenesis and obesity. According to the invention mineralcorticoid receptor antagonists are used as the therapeutically active principle. The mineralcorticoid receptor antagonists used in this invention are capable of displacing the endogenous glucocorticoid cortisol from the mineralcorticoid receptor.
MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY
CAPRIO M;
2012-01-01
Abstract
The present invention is on the field of prevention and/or treatment of adipogenesis and obesity. According to the invention mineralcorticoid receptor antagonists are used as the therapeutically active principle. The mineralcorticoid receptor antagonists used in this invention are capable of displacing the endogenous glucocorticoid cortisol from the mineralcorticoid receptor.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
